Clinical Trials Directory

Trials / Unknown

UnknownNCT05733299

Aflo™ Device Trial

Automating Patient Inhaler Technique When Using Pressurised Metered Dose Inhalers: Testing the Functionality and Impact of the Aflo™ Digital Respiratory Management Platform in a Randomised Controlled Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
University of Ulster · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Accepted

Summary

This randomised, prospective, controlled parallel study aims to evaluate the role and potential of the aflo™ digital platform for improving asthma control, inhalation technique and adherence in patients who use metred dose inhalers (MDI). The study will recruit 104 patients with uncontrolled asthma in the North-West of Northern Ireland. Fifty two patients will remain on standard care over 24-weeks and 52 will combine standard care with the aflo™ platform. The data collected over a 24-week period will be used to determine 1. whether the aflo™platform improves inhalation technique and user adherence to prescribed medication and 2. Lead to better asthma control and reduced symptoms as measured by the Asthma Control Test (ACT). During the study clinicians will be able to remotely monitor and review user analytics via a clinical dashboard. ACT measurements will be recorded at start and end of study. The study aims to test the functionality and impact of automated inhaler technique with real-time feedback, adherence prompts and air quality data sharing for patients who use metered dose inhalers (MDI) using the newly developed aflo™ digital respiratory management platform.

Conditions

Interventions

TypeNameDescription
DEVICEaflo™ digital respiratory management platformmedical device, user app, clinician portal, data analytics hub
OTHERStandard careHealth service standard care will be continued

Timeline

Start date
2023-02-06
Primary completion
2024-02-05
Completion
2024-02-05
First posted
2023-02-17
Last updated
2023-02-17

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05733299. Inclusion in this directory is not an endorsement.